Development of a Multi-Antigenic SARS-CoV-2 Vaccine Using a Synthetic Poxvirus Platform

Modified Vaccinia Ankara (MVA) is a highly attenuated poxvirus vector that is widely used to develop vaccines for infectious diseases and cancer. We developed a novel vaccine platform based on a unique three-plasmid system to efficiently generate recombinant MVA vectors from chemically synthesized D...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiuppesi, Flavia, Salazar, Marcela d’Alincourt, Contreras, Heidi, Nguyen, Vu, Martinez, Joy, Park, Soojin, Nguyen, Jenny, Kha, Mindy, Iniguez, Angelina, Zhou, Qiao, Kaltcheva, Teodora, Levytskyy, Roman, Ebelt, Nancy, Kang, Tae, Wu, Xiwei, Rogers, Tom, Manuel, Edwin, Shostak, Yuriy, Diamond, Don, Wussow, Felix
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Journal Experts 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7373143/
https://www.ncbi.nlm.nih.gov/pubmed/32702732
http://dx.doi.org/10.21203/rs.3.rs-40198/v1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7373143/
https://www.ncbi.nlm.nih.gov/pubmed/32702732
http://dx.doi.org/10.21203/rs.3.rs-40198/v1

Ejemplares similares